EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Post‐Banding Ulcer Bleeding After Endoscopic Ligation: Incidence, Risk Factors and Outcomes in Patients With Cirrhosis

Maria de Brito Nunes iD, Matthias Knecht iD, Jonas Schropp, Reiner Wiest iD, Jaume Bosch iD, Annalisa Berzigotti iD

Alimentary Pharmacology & Therapeutics · 2026

DOI: 10.1111/apt.70495 ↗

At a glance

Journal article in Alimentary Pharmacology & Therapeutics, 2026. Written by Maria de Brito Nunes and 5 co-authors. Institution: Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Major MEDLINE topics: Liver Cirrhosis, Esophageal and Gastric Varices, Gastrointestinal Hemorrhage. Cited 5 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background and Study Aim Post‐banding ulcer bleeding (PBUB) is an understudied complication of endoscopic band ligation (EBL) used in the prevention and treatment of oesophageal variceal bleeding (VB). The aim of this study is to investigate the incidence, mortality and risk factors of PBUB.

Methods

Retrospective cohort study conducted at the university hospital of Bern (Switzerland). It included patients with cirrhosis and oesophageal varices who underwent prophylactic or urgent EBL for VB between 1 January 2018 and 31 December 2022.

Results

In total, 206 patients with cirrhosis, who underwent 630 sessions of EBL, were included. The incidence rate of PBUB was 17.5% (95% CI, 12.7%–23.5%), considering the total number of patients, and 6.8% (95% CI, 5.0%–9.2%) considering the total of EBL procedures. Urgent EBL (SHR: 2.78, 95% CI: 1.29–6.00, p = 0.009) and elevated creatinine (SHR: 1.04, 95% CI: 1.01–1.07, p = 0.024) were independent risk factors for PBUB on multivariate analysis. PBUB required blood product transfusions in 88.1% of events (95% CI, 73.6%–95.5%) and hospitalisation at the intensive care unit in 74.4% of events, with a median hospital stay of 2 days (range: 1–34 days). In patients with PBUB, the short‐term mortality during hospitalisation was 19%, and long‐term mortality at 52 weeks was 64%.

Conclusions

Patients with cirrhosis undergoing urgent EBL or those with elevated creatinine levels are at increased risk of PBUB. Due to the high mortality associated with PBUB, identifying high‐risk patients and implementing preventive strategies is essential for improving patient outcomes.

Subjects

MeSH terms (MEDLINE)

Liver CirrhosisEsophageal and Gastric VaricesGastrointestinal HemorrhageHumansMaleFemaleRetrospective StudiesMiddle AgedRisk FactorsLigationIncidenceAgedTreatment Outcome

Author keywords

endoscopic band ligationliver cirrhosisoesophageal and gastric varicespost‐banding ulcer bleeding

Authors and institutions

  • Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Department of Internal Medicine, Hospital of Fribourg, Fribourg, Switzerland.
  • Graduate School for Health Sciences (GHS), University of Bern, Bern, Switzerland.

ORCID profiles: Maria de Brito Nunes, Matthias Knecht, Reiner Wiest, Jaume Bosch, Annalisa Berzigotti

Cite

APA

de Brito Nunes, M., Knecht, M., Schropp, J., Wiest, R., Bosch, J., & Berzigotti, A. (2026). Post‐Banding Ulcer Bleeding After Endoscopic Ligation: Incidence, Risk Factors and Outcomes in Patients With Cirrhosis. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70495

Vancouver

de Brito Nunes M, Knecht M, Schropp J, Wiest R, Bosch J, Berzigotti A. Post‐Banding Ulcer Bleeding After Endoscopic Ligation: Incidence, Risk Factors and Outcomes in Patients With Cirrhosis. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.70495

BibTeX
@article{deBritoNunes2026,
  author = {de Brito Nunes, Maria and Knecht, Matthias and Schropp, Jonas and Wiest, Reiner and Bosch, Jaume and Berzigotti, Annalisa},
  title = {Post‐Banding Ulcer Bleeding After Endoscopic Ligation: Incidence, Risk Factors and Outcomes in Patients With Cirrhosis},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1111/apt.70495}
}
Start for free →